Under construction – not a live service
Sign in
Taking people in SloveniaNo phase

Tracks swallowing, quality of life and attitudes toward feeding tubes in ALS

Follows adults with ALS, observing swallowing ability and views on feeding tubes.

Plain-language title generated from the registry record
Registry title: Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

Key facts

Where
Ljubljana, SloveniaSee the site

Where in Slovenia

  • University Medical Centre LjubljanaLjubljana, SloveniaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Rehabilitation Institute, Republic of Slovenia
Trial code
NCT05336760
Record updated
15 June 2026
Original description
In Amyotrophic Lateral Sclerosis, dysphagia has a high incidence. With deterioration of swallowing function, percutaneous endoscopic gastrostomy (PEG) tube is recommended to ensure sufficient and safe oral intake. Dysphagia and PEG placement alter quality of life (QoL). However, QoL and attitudes toward PEG remain largely unexplored. The purpose of this study is to monitor the swallowing function in relationship to QoL and attitudes toward PEG tube insertion and feeding.Read full original descriptionShow less

Dysphagia, Quality of Life and Attitudes Towards Percutaneous Endoscopic Gastrostomy in Patients With Amyotrophic Lateral Sclerosis

In Amyotrophic Lateral Sclerosis, dysphagia has a high incidence. With deterioration of swallowing function, percutaneous endoscopic gastrostomy (PEG) tube is recommended to ensure sufficient and safe oral intake. Dysphagia and PEG placement alter quality of life (QoL). However, QoL and attitudes toward PEG remain largely unexplored. The purpose of this study is to monitor the swallowing function in relationship to QoL and attitudes toward PEG tube insertion and feeding.

Inclusion: 18 years of age or older; diagnosis of ALS; follow-up at University Medical Centre Ljubljana, Division of Neurophysiology, every 3 months; be able to visit the study site for in-person procedures every 3 months; at least 18 years of age.

Exclusion: co-existing illness or disorder that could influence the swallowing function independently of the ALS diagnosis; clinically significant cognitive deterioration or dementia at enrollment, as determined by the ALS study neurologist; signs of probable cognitive deterioration or dementia at enrollment.

ClinicalTrials.gov NCT05336760